Guaifenesin 51660-0566
Product NDC
51660-0566- Manufacturer
- Ohm Laboratories, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- April 1, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA209254
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Packaging Options(3)
20 TABLET, EXTENDED RELEASE in 1 CARTON (51660-566-21)
40 TABLET, EXTENDED RELEASE in 1 CARTON (51660-566-41)
68 TABLET, EXTENDED RELEASE in 1 CARTON (51660-566-68)